BioNTech Investor Day Presentation Deck

Marburg is our largest manufacturing site BioNTech's Marburg site is one of the largest mRNA vaccine manufacturing sites Supply of mRNA for more than 1.2 bn doses of the COVID-19 vaccine in 2021 as part of a European manufacturing network 50% boost in staff planned in 2022 (+ 250 jobs) EUR 50 million to be invested in Marburg site in 2022 BIONTECH

View entire presentation